The Hallmarks of Cancer Revisited Through Systems Biology and Network Modelling
暂无分享,去创建一个
Charles Auffray | Trey Ideker | Leroy Hood | David J. Galas | L. Hood | T. Ideker | C. Auffray | D. Galas
[1] Ji Luo,et al. Cancer Proliferation Gene Discovery Through Functional Genomics , 2008, Science.
[2] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[3] Jeong-Rae Kim,et al. Inferring biomolecular regulatory networks from phase portraits of time‐series expression profiles , 2006, FEBS letters.
[4] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[5] D. Cleveland,et al. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis , 2009, Nature Reviews Molecular Cell Biology.
[6] P. Maini,et al. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer , 2007, Proceedings of the National Academy of Sciences.
[7] Simo V. Zhang,et al. A map of human cancer signaling , 2007, Molecular systems biology.
[8] Alvis Brazma,et al. Modelling gene networks at different organisational levels , 2005, FEBS letters.
[9] David Warde-Farley,et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.
[10] A. Barabasi,et al. Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.
[11] L. Hood,et al. A Genomic Regulatory Network for Development , 2002, Science.
[12] Martin Vingron,et al. A systems biological approach suggests that transcriptional feedback regulation by dual‐specificity phosphatase 6 shapes extracellular signal‐related kinase activity in RAS‐transformed fibroblasts , 2009, The FEBS journal.
[13] Rakesh Nagarajan,et al. Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia , 2008, Genome Biology.
[14] R. Sun,et al. Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.
[15] Bernhard Ø Palsson,et al. Understanding human metabolic physiology: a genome-to-systems approach. , 2009, Trends in biotechnology.
[16] J. Weinstein,et al. Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.
[17] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[18] P. Sorger,et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.
[19] L. Hood,et al. Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. , 2008, Medical hypotheses.
[20] H. Westerhoff,et al. Recurrent design patterns in the feedback regulation of the mammalian signalling network , 2008, Molecular systems biology.
[21] Elaine Holmes,et al. The challenges of modeling mammalian biocomplexity , 2004, Nature Biotechnology.
[22] Eyal Gottlieb,et al. Metabolic transformation in cancer. , 2009, Carcinogenesis.
[23] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[24] Edward C Stites,et al. Network Analysis of Oncogenic Ras Activation in Cancer , 2007, Science.
[25] C. Sawyers. The cancer biomarker problem , 2008, Nature.
[26] D-M Hu,et al. Time-dependent sensitivity analysis of biological networks: coupled MAPK and PI3K signal transduction pathways. , 2006, The journal of physical chemistry. A.
[27] G. Friedlander,et al. Regulation of gene expression by small non-coding RNAs: a quantitative view , 2007, Molecular systems biology.
[28] Mark Gerstein,et al. Systematic analysis of transcribed loci in ENCODE regions using RACE sequencing reveals extensive transcription in the human genome , 2008, Genome Biology.
[29] T. Seyfried,et al. Cancer as a metabolic disease , 2010, Nutrition & metabolism.
[30] Robin Mathew,et al. Role of autophagy in cancer , 2007, Nature Reviews Cancer.
[31] P. Shannon,et al. Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing , 2010, Science.
[32] Neil J Ganem,et al. Tetraploidy, aneuploidy and cancer. , 2007, Current opinion in genetics & development.
[33] K. Basso,et al. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas , 2008, Molecular systems biology.
[34] O. Demin,et al. The Edinburgh human metabolic network reconstruction and its functional analysis , 2007, Molecular systems biology.
[35] Atul J Butte,et al. The Ultimate Model Organism , 2008, Science.
[36] Charles Auffray,et al. Scale relativity theory and integrative systems biology: 2. Macroscopic quantum-type mechanics. , 2008, Progress in biophysics and molecular biology.
[37] Bernhard O. Palsson,et al. Iterative Reconstruction of Transcriptional Regulatory Networks: An Algorithmic Approach , 2006, PLoS Comput. Biol..
[38] Barbara M. Bakker,et al. Metabolic control analysis to identify optimal drug targets. , 2007, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[39] Christina Yau,et al. Ageing, oxidative stress and cancer: paradigms in parallax , 2008, Nature Reviews Cancer.
[40] William J. Bosl,et al. Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery , 2007, BMC Systems Biology.
[41] Jeffrey T. Chang,et al. A genomic strategy to elucidate modules of oncogenic pathway signaling networks. , 2009, Molecular cell.
[42] Erwin P. Gianchandani,et al. Systems analyses characterize integrated functions of biochemical networks. , 2006, Trends in biochemical sciences.
[43] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[44] Angelika Amon,et al. Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells , 2008, Science.
[45] Pedro de Atauri,et al. Metabolic control analysis in drug discovery and disease , 2002, Nature Biotechnology.
[46] John T. Wei,et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. , 2005, Cancer cell.
[47] Gudmundur A. Thorisson,et al. Genotype–phenotype databases: challenges and solutions for the post-genomic era , 2009, Nature Reviews Genetics.
[48] Erwin P. Gianchandani,et al. Flux balance analysis in the era of metabolomics , 2006, Briefings Bioinform..
[49] Douglas A Lauffenburger,et al. RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects. , 2009, Cancer research.
[50] Simon Kasif,et al. Biological context networks: a mosaic view of the interactome , 2006, Molecular Systems Biology.
[51] Paula D. Bos,et al. Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.
[52] Angelika Amon,et al. Aneuploidy: Cells Losing Their Balance , 2008, Genetics.
[53] Zhi Hu,et al. Integrated analysis of breast cancer cell lines reveals unique signaling pathways , 2009, Genome Biology.
[54] John J. Tyson,et al. Temporal Organization of the Cell Cycle , 2008, Current Biology.
[55] Jiri Bartek,et al. An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.
[56] M. Bizzarri,et al. Beyond the Oncogene Paradigm: Understanding Complexity in Cancerogenesis , 2008, Acta biotheoretica.
[57] Marta Cascante,et al. Metabolomics and fluxomics approaches. , 2008, Essays in biochemistry.
[58] Richard Bonneau,et al. Learning global models of transcriptional regulatory networks from data. , 2009, Methods in molecular biology.
[59] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[60] T. Deisboeck,et al. Simulating non-small cell lung cancer with a multiscale agent-based model , 2007, Theoretical Biology and Medical Modelling.
[61] D. Lauffenburger,et al. Multipathway Model Enables Prediction of Kinase Inhibitor Cross-Talk Effects on Migration of Her2-Overexpressing Mammary Epithelial Cells , 2008, Molecular Pharmacology.
[62] M. Tewari,et al. The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative? , 2006, PLoS medicine.
[63] Marc W Kirschner,et al. The Meaning of Systems Biology , 2005, Cell.
[64] A. Ullrich,et al. Paul Ehrlich's magic bullet concept: 100 years of progress , 2008, Nature Reviews Cancer.
[65] A. Citri,et al. EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.
[66] B. Zhivotovsky,et al. Mitochondria in cancer cells: what is so special about them? , 2008, Trends in cell biology.
[67] S. McDougall,et al. Mathematical modeling of tumor-induced angiogenesis. , 2006, Annual review of biomedical engineering.
[68] L. Hood,et al. A data integration methodology for systems biology: experimental verification. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[69] J. Hoeijmakers,et al. DNA damage and ageing: new-age ideas for an age-old problem , 2008, Nature Cell Biology.
[70] Ji Luo,et al. Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.
[71] U. Alon. Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.
[72] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[73] Wei Keat Lim,et al. The transcriptional network for mesenchymal transformation of brain tumors , 2009, Nature.
[74] K. Gunsalus,et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. , 2007, Nature genetics.
[75] I. Weinstein. Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.
[76] V. Grantcharova,et al. Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis , 2009, Science Signaling.
[77] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[78] Zhihui Wang,et al. Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model , 2009, Bioinform..
[79] Alberto Mantovani,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[80] R. Weinberg,et al. The Biology of Cancer , 2006 .
[81] M. L. Martins,et al. Reaction-diffusion model for the growth of avascular tumor. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.
[82] Judit Ovádi,et al. On the origin of intracellular compartmentation and organized metabolic systems , 2004, Molecular and Cellular Biochemistry.
[83] Amy K. Schmid,et al. A Predictive Model for Transcriptional Control of Physiology in a Free Living Cell , 2007, Cell.
[84] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[85] S. Lindquist,et al. HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.
[86] P. Bork,et al. Systematic Discovery of In Vivo Phosphorylation Networks , 2007, Cell.
[87] D. Noble. Modeling the Heart--from Genes to Cells to the Whole Organ , 2002, Science.
[88] D. Noble. Claude Bernard, the first systems biologist, and the future of physiology , 2008, Experimental physiology.
[89] Denis Noble,et al. The Cardiac Physiome: perspectives for the future , 2009, Experimental physiology.
[90] P. Carroll,et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention , 2008, Proceedings of the National Academy of Sciences.
[91] Stephen J. Elledge,et al. Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening , 2008, Science.
[92] R. Sharan,et al. Protein networks in disease. , 2008, Genome research.
[93] J. Nevins,et al. Linking oncogenic pathways with therapeutic opportunities , 2006, Nature Reviews Cancer.
[94] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[95] James J Collins,et al. Systems biology makes it personal. , 2009, Molecular cell.
[96] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[97] Richard Bonneau,et al. The Inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo , 2006, Genome Biology.
[98] M. Girolami,et al. Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques , 2006, Journal of The Royal Society Interface.
[99] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[100] T. Ideker,et al. A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.
[101] Dimitris Kletsas,et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.
[102] J. Tyson,et al. Design principles of biochemical oscillators , 2008, Nature Reviews Molecular Cell Biology.
[103] Kathy Chen,et al. Network dynamics and cell physiology , 2001, Nature Reviews Molecular Cell Biology.
[104] S. Kauffman,et al. Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. , 2009, Seminars in cell & developmental biology.
[105] Neema Jamshidi,et al. A genome-scale, constraint-based approach to systems biology of human metabolism. , 2007, Molecular bioSystems.
[106] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[107] Liming Yang,et al. A loss-of-function RNA interference screen for molecular targets in cancer , 2006, Nature.
[108] R. Milo,et al. Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[109] P. Shannon,et al. Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. , 2005, Cancer research.
[110] J Wade Harper,et al. The DNA damage response: ten years after. , 2007, Molecular cell.
[111] Charles Auffray,et al. Deciphering cellular states of innate tumor drug responses , 2006, Genome Biology.
[112] Jason A. Papin,et al. Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.
[113] Albert,et al. Emergence of scaling in random networks , 1999, Science.
[114] Charles Auffray,et al. Protein subnetwork markers improve prediction of cancer outcome , 2007, Molecular systems biology.
[115] Richard Bonneau. Learning biological networks: from modules to dynamics. , 2008, Nature chemical biology.
[116] E. Davidson,et al. Global regulatory logic for specification of an embryonic cell lineage , 2008, Proceedings of the National Academy of Sciences.
[117] Christopher L. McClendon,et al. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.
[118] Olaf Wolkenhauer,et al. Systems biologists seek fuller integration of systems biology approaches in new cancer research programs. , 2010, Cancer research.
[119] D. Lauffenburger,et al. Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.
[120] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[121] Krin A. Kay,et al. The implications of human metabolic network topology for disease comorbidity , 2008, Proceedings of the National Academy of Sciences.
[122] Jens Timmer,et al. Systems-level interactions between insulin–EGF networks amplify mitogenic signaling , 2009, Molecular systems biology.
[123] Amy E. Hawkins,et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.
[124] Mark W. Dewhirst,et al. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.
[125] L. Hood,et al. Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.
[126] T. Barrette,et al. Probabilistic model of the human protein-protein interaction network , 2005, Nature Biotechnology.
[127] Stefan Bornholdt,et al. Topology of biological networks and reliability of information processing , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[128] T. Pawson,et al. Oncogenic re-wiring of cellular signaling pathways , 2007, Oncogene.
[129] Charles Auffray,et al. A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer , 2009, PloS one.
[130] Guido Kroemer,et al. Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.
[131] J. Pouysségur,et al. Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.
[132] Jason A. Papin,et al. Metabolic pathways in the post-genome era. , 2003, Trends in biochemical sciences.
[133] P. Comoglio,et al. The Met pathway: master switch and drug target in cancer progression , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[134] Dimitris Kletsas,et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.
[135] Peter Oster,et al. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus. , 2008, Patient education and counseling.
[136] Hamid Bolouri,et al. A data integration methodology for systems biology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[137] E. Fraenkel,et al. Integrating Proteomic, Transcriptional, and Interactome Data Reveals Hidden Components of Signaling and Regulatory Networks , 2009, Science Signaling.
[138] Weiping Zou,et al. Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.
[139] Alissa M. Weaver,et al. Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment , 2006, Cell.
[140] Tony Pawson,et al. Comparative Analysis Reveals Conserved Protein Phosphorylation Networks Implicated in Multiple Diseases , 2009, Science Signaling.
[141] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[142] Olaf Wolkenhauer,et al. Report on EU–USA Workshop: How Systems Biology Can Advance Cancer Research (27 October 2008) , 2009, Molecular oncology.
[143] Inyoul Y. Lee,et al. A systems approach to prion disease , 2009, Molecular systems biology.
[144] Steffen Klamt,et al. The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data , 2009, PLoS Comput. Biol..
[145] Douglas A Lauffenburger,et al. Quantitative modeling perspectives on the ErbB system of cell regulatory processes. , 2008, Experimental cell research.
[146] Michael B. Yaffe,et al. Data-driven modelling of signal-transduction networks , 2006, Nature Reviews Molecular Cell Biology.
[147] Olaf Wolkenhauer,et al. Systems Biology: the Reincarnation of Systems Theory Applied in Biology? , 2001, Briefings Bioinform..
[148] W. Kaelin. The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.
[149] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[150] R. Bernards,et al. Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.
[151] Michael E Phelps,et al. Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.
[152] D. Noble,et al. Systems biology and the virtual physiological human , 2009, Molecular systems biology.
[153] H. Byrne. Dissecting cancer through mathematics: from the cell to the animal model , 2010, Nature Reviews Cancer.
[154] C. Auffray,et al. Scale relativity theory and integrative systems biology: 1. Founding principles and scale laws. , 2008, Progress in biophysics and molecular biology.
[155] D. Ransohoff,et al. Sources of bias in specimens for research about molecular markers for cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[156] Jelena Pjesivac-Grbovic,et al. A multiscale model for avascular tumor growth. , 2005, Biophysical journal.
[157] A. Chinnaiyan,et al. Integrative analysis of the cancer transcriptome , 2005, Nature Genetics.
[158] Charles Auffray,et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[159] David J. Galas,et al. Markov Logic Networks in the Analysis of Genetic Data , 2010, J. Comput. Biol..
[160] Liang Tong,et al. Targeting the Human Cancer Pathway Protein Interaction Network by Structural Genomics* , 2008, Molecular & Cellular Proteomics.
[161] G. Tonon,et al. From oncogene to network addiction: the new frontier of cancer genomics and therapeutics. , 2008, Future oncology.
[162] Charles Auffray,et al. Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. , 2005, Blood.
[163] M. Tewari,et al. The Clinical Applications of a Systems Approach , 2006, PLoS medicine.
[164] Irving L. Weissman,et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.
[165] Didier Bresch,et al. A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy. , 2009, Journal of theoretical biology.
[166] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[167] David J Foran,et al. Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapy , 2008, The Prostate.
[168] Gilles Clermont,et al. Bridging the gap between systems biology and medicine , 2009, Genome Medicine.
[169] B. Palsson,et al. The evolution of molecular biology into systems biology , 2004, Nature Biotechnology.
[170] Mark Gerstein,et al. Network Modeling Identifies Molecular Functions Targeted by miR-204 to Suppress Head and Neck Tumor Metastasis , 2010, PLoS Comput. Biol..
[171] G. Song,et al. Role of hypoxia in the hallmarks of human cancer , 2009, Journal of cellular biochemistry.
[172] Gilles Clermont,et al. BMC Systems Biology , 2022 .
[173] Julio Saez-Rodriguez,et al. Fuzzy Logic Analysis of Kinase Pathway Crosstalk in TNF/EGF/Insulin-Induced Signaling , 2007, PLoS Comput. Biol..
[174] S. Elledge,et al. Non-Oncogene Addiction and the Stress Phenotype of Cancer Cells , 2007, Cell.
[175] V. Quaranta,et al. Integrative mathematical oncology , 2008, Nature Reviews Cancer.
[176] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[177] David F Ransohoff,et al. Promises and limitations of biomarkers. , 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[178] Charles Auffray,et al. From functional genomics to systems biology: concepts and practices. , 2003, Comptes rendus biologies.
[179] Robert A Beckman,et al. Genetic instability in cancer: theory and experiment. , 2005, Seminars in cancer biology.
[180] Ignacio Ramis-Conde,et al. Multi-scale modelling of cancer cell intravasation: the role of cadherins in metastasis , 2009, Physical biology.
[181] G. Bhanot,et al. Autophagy Suppresses Tumorigenesis through Elimination of p62 , 2009, Cell.
[182] Marta Cascante,et al. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. , 2002, Drug discovery today.
[183] Alan Ashworth,et al. Bringing DNA Repair in Tumors into Focus , 2009, Clinical Cancer Research.
[184] S. McDougall,et al. Multiscale modelling and nonlinear simulation of vascular tumour growth , 2009, Journal of mathematical biology.
[185] Pamela K. Kreeger,et al. Cancer systems biology: a network modeling perspective , 2009, Carcinogenesis.
[186] Izhak Haviv,et al. Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.
[187] John T. Wei,et al. Integrative molecular concept modeling of prostate cancer progression , 2007, Nature Genetics.
[188] H. Kotani,et al. Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation , 2008, Current genomics.
[189] Charles Auffray,et al. Origins of Systems Biology in William Harvey’s Masterpiece on the Movement of the Heart and the Blood in Animals , 2009, International journal of molecular sciences.
[190] Kornelia Polyak,et al. Microenvironmental regulation of cancer development. , 2008, Current opinion in genetics & development.
[191] A. Barabasi,et al. Cancer metastasis networks and the prediction of progression patterns , 2009, British Journal of Cancer.
[192] Hongbin Sun,et al. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies. , 2009, Current medicinal chemistry.
[193] J. Folkman. Opinion: Angiogenesis: an organizing principle for drug discovery? , 2007, Nature Reviews Drug Discovery.
[194] B. Williams,et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.
[195] K. Kinzler,et al. Gene expression analysis goes digital , 2007, Nature Biotechnology.
[196] E. Zerhouni. Translational and clinical science--time for a new vision. , 2005, The New England journal of medicine.
[197] M. Vidal,et al. Interactome: gateway into systems biology. , 2005, Human molecular genetics.
[198] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[199] David J. Galas,et al. Maximal Extraction of Biological Information from Genetic Interaction Data , 2009, PLoS Comput. Biol..
[200] D. Fell. Enzymes, metabolites and fluxes. , 2004, Journal of experimental botany.